Ardeparin and danaparoid.
D000925:Anticoagulants / Q000627:therapeutic use*; D001682:Biological Availability; D002809:Chondroitin Sulfates / Q000627:therapeutic use*; D003871:Dermatan Sulfate / Q000627:therapeutic use*; D004338:Drug Combinations; D016903:Drug Monitoring / Q000451:nursing; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006497:Heparan Sulfate / Q000627:therapeutic use*; D006801:Humans; D020246:Venous Thrombosis / Q000517:prevention & control*
D000925:Anticoagulants; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D004338:Drug Combinations; D006495:Heparin, Low-Molecular-Weight; D006497:Heparan Sulfate; C035838:danaparoid; C093450:ardeparin